title: Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16.
abstract: OBJECTIVE
  To study the clinical recovery from acute otitis media (AOM) in children, 2-16 years of age, managed with or without treatment with phenoxymethylpenicillin (PcV).
  
  
  METHODS
  An open, prospective randomized trial. Children aged between 2 and 16 years, presenting with one- or double-sided AOM (without perforation) with symptom duration of less than four days, were included. The children were randomized to PcV for five days or to no primary antibiotic treatment. A health score and compliance were registered on a daily basis for seven days.
  
  
  METHODS
  A total of 32 health centres and 72 GPs in south-east Sweden. Subjects. Children aged 2-16 presenting with earache.
  
  
  METHODS
  Recovery time, symptom duration, frequency of complications (up to three months) and consumption of healthcare services independent of treatment with or without antibiotics.
  
  
  RESULTS
  A total of 179 patients carried out the trial; 92 were randomized to PcV, 87 to no primary antibiotic treatment. The median recovery time was four days in both groups. Patients who received PcV had less pain (p <0.001) and used fewer analgesics. There were no significant differences in the number of middle-ear effusions or perforations at the final control after three months. Children randomized to PcV treatment consulted less (p <0.001) during the first seven days.
  
  
  CONCLUSIONS
  Our investigation supports that PcV treatment of AOM does not affect the recovery time or complication rates. PcV provided some symptomatic benefit in the treatment of AOM in otherwise healthy children, aged 2-16 years.
authors.affiliation: Lindsdal Primary Health Centre, Kalmar, Sweden. thomasn@ltkalmar.se
authors.forename: Thomas
authors.initials: T
authors.lastname: Neumark
authors.forename: Sigvard
authors.initials: S
authors.lastname: Mölstad
authors.forename: Christer
authors.initials: C
authors.lastname: Rosén
authors.forename: Lars-Göran
authors.initials: LG
authors.lastname: Persson
authors.forename: Annika
authors.initials: A
authors.lastname: Törngren
authors.forename: Lars
authors.initials: L
authors.lastname: Brudin
authors.forename: Ingvar
authors.initials: I
authors.lastname: Eliasson
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004433:Earache / Q000175:diagnosis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010033:Otitis Media / Q000188:drug therapy*; D010147:Pain Measurement; D010404:Penicillin V / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D010404:Penicillin V